Deferred Tax Assets, Valuation Allowance in USD of Adicet Bio, Inc. from Q4 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Adicet Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2017 to Q4 2024.
  • Adicet Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $119M, a 20.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Adicet Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $119M +$20.2M +20.4% 31 Dec 2024 10-K 06 Mar 2025
Q4 2023 $99.1M +$9.58M +10.7% 31 Dec 2023 10-K 06 Mar 2025
Q4 2022 $89.5M +$16.3M +22.3% 31 Dec 2022 10-K 19 Mar 2024
Q4 2021 $73.2M +$15.4M +26.8% 31 Dec 2021 10-K 15 Mar 2023
Q4 2020 $57.7M +$37.9M +191% 31 Dec 2020 10-K 15 Mar 2022
Q4 2019 $19.8M +$8.08M +68.8% 31 Dec 2019 10-K 12 Mar 2021
Q4 2018 $11.7M +$6.43M +121% 31 Dec 2018 10-K 12 Mar 2021
Q4 2017 $5.31M 31 Dec 2017 10-K 18 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.